1. Gamma-Klotho exhibits multiple roles in tumor growth of human bladder cancer
   Shunta Hori et al, 2018, Oncotarget CrossRef
2. Fibroblast growth factor receptor 4 (FGFR4) as detected by immunohistochemistry is associated with postoperative residual disease in ovarian cancer
   Sabine Heublein et al, 2019, Journal of Cancer Research and Clinical Oncology CrossRef
3. Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles
   Meysam Yousefi et al, 2020, Cellular Oncology CrossRef
4. The FGFR Family Inhibitor AZD4547 Exerts an Antitumor Effect in Ovarian Cancer Cells
   Yu Ran Na et al, 2021, International Journal of Molecular Sciences CrossRef
5. Ponatinib and gossypol act in synergy to suppress colorectal cancer cells by modulating apoptosis/autophagy crosstalk and inhibiting the FGF19/FGFR4 axis
   Naglaa M. El-Lakkany et al, 2023, Asian Pacific Journal of Tropical Biomedicine CrossRef
6. Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives
   Emmanuel Somm et al, 2018, Endocrine Reviews CrossRef
7. Fibroblast Growth Factor Receptor 4 Targeting in Cancer: New Insights into Mechanisms and Therapeutic Strategies
   Liwei Lang et al, 2019, Cells CrossRef
8. FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer
   Wei Zhu et al, 2023, PeerJ CrossRef
9. Interrupting the FGF19-FGFR4 Axis to Therapeutically Disrupt Cancer Progression
   Liwei Lang et al, 2018, Current Cancer Drug Targets CrossRef
10. Making Way for Suppressing the FGF19/FGFR4 Axis in Cancer
    Nestor Prieto-Dominguez et al, 2018, Future Medicinal Chemistry CrossRef
11. The anti-tumor effects of AZD4547 on ovarian cancer cells: differential responses based on c-Met and FGF19/FGFR4 expression
    Yoo-Young Lee et al, 2024, Cancer Cell International CrossRef
12. Comprehensive in silico analysis of prognostic and immune infiltrates for FGFs in human ovarian cancer
    Yu Wang et al, 2024, Journal of Ovarian Research CrossRef
13. Microarray-based identification of differentially expressed genes associated with andrographolide derivatives-induced resistance in colon and prostate cancer cell lines
    Shun Ying Quah et al, 2021, Toxicology and Applied Pharmacology CrossRef
14. Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement
    Álvaro Quintanal-Villalonga et al, 2017, Clinical Lung Cancer CrossRef
15. MicroRNA-520e restricts the proliferation and invasion of glioma cells through the downregulation of Wnt/β-catenin signaling by targeting fibroblast growth factor 19
    Liang Zhang et al, 2019, Biochemical and Biophysical Research Communications CrossRef
16. The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction
    Álvaro Quintanal-Villalonga et al, 2018, Scientific Reports CrossRef
17. Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7
    Sabine Heublein et al, 2024, Laboratory Investigation CrossRef
18. The fibroblast growth factor 8 family in the female reproductive tract
    Anthony Estienne et al, 2018, Reproduction CrossRef